FDA daily for Sunday, February 4, 2024
In this issue: 1 device decision and 19 label changes.
Device clearances and approvals
FDA date:FDA decided 0 510(k)s and 1 PMA decision on Sun, Jan 21.
Browse device clearances and approvals in FDA data →Label updates
FDA date:19 drug labels took effect on Sun, Jan 21. Below: those, and labels carrying a boxed warning.
- LORAZEPAM
LORAZEPAM · A-S Medication Solutions · ORAL
- NP THYROID 30
LEVOTHYROXINE, LIOTHYRONINE · A-S Medication Solutions · ORAL
- Olmesartan Medoxomil and Hydrochlorothiazide
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE · A-S Medication Solutions · ORAL
How the FDA daily is written
Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.
Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.
